Skip to main content
ENSC
NASDAQ Life Sciences

Cash Falls Sharply as Ensysce Biosciences Reports Widening Q1 Net Loss

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.278
Mkt Cap
$2.599M
52W Low
$0.23
52W High
$2.75
52W Position info
21% above low
Off High info
90% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

ENSC sits 21% above its 52-week low of $0.23 on light trading volume (0.1× avg).

Summary

Ensysce Biosciences reported a significant widening of its Q1 net loss to $3.60 million, accompanied by a sharp decline in its cash position. The increased loss was primarily driven by higher external research and development costs associated with Phase 3 clinical trial activity for PF614, while federal grant funding also decreased. This financial update is critical for the micro-cap biotech, as a substantial cash burn raises concerns about its operational runway and ability to sustain its costly R&D pipeline, especially given the expectation of continued losses. Traders will be closely watching for any future financing announcements or updates on cash management strategies.

At the time of this announcement, ENSC was trading at $0.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $0.23 to $2.75. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ENSC - Latest Insights

ENSC
Nov 12, 2026, 11:18 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.380
Real-time Price: $0.4095 info
Change: +$0.0295 (+8%) info
Market Cap: $7.968M info
ENSC
Nov 12, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.4095 info
Change: +$0.0224 (+6%) info
Market Cap: $7.968M info
ENSC
Nov 12, 2026, 4:17 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.4095 info
Change: +$0.0224 (+6%) info
Market Cap: $7.968M info
ENSC
Nov 12, 2026, 4:15 PM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.3871
Real-time Price: $0.4095 info
Change: +$0.0224 (+6%) info
Market Cap: $7.968M info
ENSC
Nov 04, 2026, 12:46 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3719
Real-time Price: $0.4095 info
Change: +$0.0376 (+10%) info
Market Cap: $7.968M info